Zongmeng Zhang

Dr. Zongmeng Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ZZZongmeng Zhang
Zongmeng Zhang
JDJinlin Du
Jinlin Du
QXQihua Xu
Qihua Xu
CXChaofeng Xing
Chaofeng Xing
YLYuyu Li
Yuyu Li
FLFanghong Li
Fanghong Li
Adiponectin is an adipocytokine with anti-inflammatory and anticancer properties. Our previous study has shown that blood adiponectin levels were inversely correlated to the risk of nasopharyngeal carcinoma (NPC), and that adiponectin could directly suppress the proliferation of NPC cells. However, the effect of adiponectin on NPC metastasis remains unknown. Here, we revealed in clinical studies that serum adiponectin level was inversely correlated with tumor stage, recurrence, and metastasis in NPC patients, and that low serum adiponectin level also correlates with poor metastasis-free survival. Coculture with recombinant adiponectin suppressed the migration and invasion of NPC cells as well as epithelial–mesenchymal transition (EMT). In addition, recombinant adiponectin dampened the activation of NF-κB and STAT3 signaling pathways induced by adipocyte-derived proinflammatory factors such as leptin, IL-6, and TNF-α. Pharmacological activation of adiponectin receptor through its specific agonist, AdipoRon, largely stalled the metastasis of NPC cells. Taken together, these findings demonstrated that adiponectin could not only regulate metabolism and inhibit cancer growth, but also suppress the metastasis of NPC. Pharmacological activation of adiponectin receptor may be a promising therapeutic strategy to stall NPC metastasis and extend patients’ survival.

5 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
ZZZongmeng Zhang
Zongmeng Zhang
JDJinlin Du
Jinlin Du
QXQihua Xu
Qihua Xu
YLYuyu Li
Yuyu Li
SZSujin Zhou
Sujin Zhou
FLFanghong Li
Fanghong Li
NPC is a type of malignant tumor with a high risk of local invasion and early distant metastasis. Resistin is an inflammatory cytokine that is predominantly produced from the immunocytes in humans. Accumulating evidence has suggested a clinical association of circulating resistin with the risk of tumorigenesis and a relationship between blood resistin levels and the risk of cancer metastasis. In this study, we explored the blood levels and the role of resistin in NPC. High resistin levels in NPC patients were positively associated with lymph node metastasis, and resistin promoted the migration and invasion of NPC cells in vitro. These findings were also replicated in a mouse model of NPC tumor metastasis. We identified TLR4 as a functional receptor in mediating the pro-migratory effects of resistin in NPC cells. Furthermore, p38 MAPK and NF-κB were intracellular effectors that mediated resistin-induced EMT. Taken together, our results suggest that resistin promotes NPC metastasis by activating the TLR4/p38 MAPK/NF-κB signaling pathways.

5 March 2021 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
CSChangfeng Shan
Changfeng Shan
RWRonghua Wang
Ronghua Wang
SWShuai Wang
Shuai Wang
ZZZongmeng Zhang
Zongmeng Zhang
CXChaofeng Xing
Chaofeng Xing
FLFanghong Li
Fanghong Li

18 June 2026 in Phytotherapy Research
Verified
Journal Article
Closed access
DYDaolun Yu
Daolun Yu
KGKai Ge
Kai Ge
NCNai-Dong Chen
Nai-Dong Chen
YGYinuo Gong
Yinuo Gong
HXHangbo Xu
Hangbo Xu
ZZZongmeng Zhang
Zongmeng Zhang

1 May 2026 in Food Science and Human Wellness
Verified
Journal Article
Open access
PDF file
DYDaolun Yu
Daolun Yu
KGKai Ge
Kai Ge
NCNaidong Chen
Naidong Chen
ZHZhiqiang He
Zhiqiang He
YGYinuo Gong
Yinuo Gong
ZZZongmeng Zhang
Zongmeng Zhang
Kidney injury is one of the common side effects in cancer patients receiving chemotherapy. Enhancement of renal antioxidant and anti-inflammation function are important strategies to combat chemotherapy-induced kidney injury. In this study, we successfully isolated a novel water-soluble polysaccharide (PCP, Mw: 55.245 kDa) from Poria cocos sclerotia, which features an α-1,4-D-Glcp backbone with branches linked at the O-6 positions. In vitro, PCP significantly relieved oxidative damage and apoptosis caused by the chemotherapeutic agent cisplatin in renal tubular epithelial cells (RTECs). In vivo, pretreatment with PCP attenuated cisplatin-induced kidney injury by mitigating oxidative stress, apoptosis, and inflammation. Furthermore, post-treatment with PCP facilitated the recovery of renal function following kidney injury. In chronic kidney injury model, PCP exhibited a persistent nephroprotective effect in inhibiting the progression of chronic kidney disease and fibrosis. Mechanistically, PCP protected RTECs from cisplatin by activating the Nrf2 signaling pathway. Importantly, PKCζ was identified as the upstream kinase responsible for initiating the phosphorylation activation of Nrf2. Taken together, PCP confers protection against cisplatin-induced kidney injury by activating the PKCζ-Nrf2 signaling pathway, suggesting that PCP may be a promising clinical candidate for the treatment of chemotherapy-induced kidney injury.

29 December 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
GSGaocheng Shi
Gaocheng Shi
HMHuihui Meng
Huihui Meng
ZZZongmeng Zhang
Zongmeng Zhang
GZGuanglei Zhang
Guanglei Zhang
YLYanran Li
Yanran Li
HYHao Yu
Hao Yu
Background/Objectives: Myocardial ischemia–reperfusion injury (MIRI) is characterized by the exacerbation of tissue damage following the restoration of blood flow to the myocardium. Chuju, recognized for its homology of food and medicine, is derived from the dried capitulum of Dendranthema morifolium (Ramat.), cultivated in Chuzhou, Anhui Province, China. Our previous studies have demonstrated that the total flavonoids extracted from Chuju (TFCJ) exhibit pharmacological efficacy against MIRI. This study will further elucidate its protective mechanism. Methods: We employed an integrative approach combining untargeted metabolomics, network pharmacology, molecular docking, and in vitro experiments to elucidate the mechanistic basis of TFCJ’s protective effects against MIRI. Results: TFCJ protected H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis. Integrated analyses identified Nrf2 as a central regulatory node activated by AKT signaling, which, in turn, modulates antioxidant protein expression and glutathione metabolism. Further in vitro experiments demonstrated that TFCJ induced AKT phosphorylation, thereby promoting Nrf2 activation and upregulating HO-1 expression, along with genes involved in glutathione synthesis. Conclusions: TFCJ exerts cardioprotective effects by activating the AKT-Nrf2 signaling pathway, regulating the expression of antioxidant and anti-apoptotic genes, and coordinating downstream glutathione metabolism, ultimately maintaining the oxidative-apoptotic balance in myocardial cells.